Physician profile
James E Pipes
NPI 1316473721
$11,609.46
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.87 · 2021: $7,553 · 2022: $2,542 · 2023: $740 · 2024: $495 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.21 |
| Travel and Lodging | $249.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $6,262.37 | 2020-2022 | |
| Arthrex, INC. | $3,222.16 | 2021-2022 | |
| Organogenesis INC. | $828.83 | 2021-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Treace Medical Concepts, INC. | $636.36 | 2021-2024 | |
| Smith+Nephew, INC. | $282.52 | 2021-2025 | Renasys Go V2 Home, Collagenase Santyl, Regranex |
| Stryker Corporation | $115.53 | 2021-2025 | Salvation, Variax |
| Lifenet Health | $98.33 | 2024 | Theragenesis Wound Matrix |
| Abbvie INC. | $77.05 | 2024-2025 | |
| Abbott Laboratories | $47.23 | 2022-2025 | Proclaim |
| Bioventus LLC | $15.15 | 2022 | |
| Solventum Corporation | $14.76 | 2025 | Activ.A.C. |
| Medela LLC | $9.17 | 2023 | Invia Motion Endure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pipes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.